Lord, Abbett & Co’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Buy
247,640
+68,351
+38% +$6.25M 0.07% 285
2026
Q1
$6.65M Buy
+179,289
New +$5.74M 0.02% 414
2024
Q1
Sell
-147,136
Closed -$3.9M 538
2023
Q4
$3.9M Sell
147,136
-806,538
-85% -$23.5M 0.01% 486
2023
Q3
$43.6M Buy
953,674
+558,908
+142% +$25.9M 0.16% 185
2023
Q2
$16.3M Buy
394,766
+65,820
+20% +$2.16M 0.06% 376
2023
Q1
$10.2M Buy
+328,946
New +$10.6M 0.04% 414

Other funds holding AEHR

Lord, Abbett & Co's AEHR Position: Q2 2026 in Review

Lord, Abbett & Co increased its Aehr Test Systems (AEHR) stake by 38% in Q2 2026, buying an estimated $6.25M and bringing the position to 247,640 shares worth $23.8M. The position accounts for 0.07% of the portfolio, ranked #285.

Lord, Abbett & Co first reported a position in AEHR in Q1 2023 and has held it in 6 quarters since. The position peaked at $43.6M in Q3 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Lord, Abbett & Co held 247,640 shares of Aehr Test Systems worth $23.8M as of Q2 2026.
  • Lord, Abbett & Co bought 68,351 Aehr Test Systems shares in Q2 2026, an estimated $6.25M.
  • Aehr Test Systems made up 0.07% of Lord, Abbett & Co's portfolio in Q2 2026, its #285 holding.
  • Lord, Abbett & Co first reported a position in Aehr Test Systems in Q1 2023 and has held it in 6 quarters since.
  • Lord, Abbett & Co's Aehr Test Systems position peaked at $43.6M in Q3 2023.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.